查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2014717

心臟瓣膜器械市場：2026-2032年全球市場預測（按瓣膜位置、產品類型、手術類型、年齡層、最終用戶和分銷管道分類）

Heart Valve Devices Market by Valve Position, Product Type, Procedure Type, Age Group, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，心臟瓣膜設備市場價值將達到 132.6 億美元，到 2026 年將成長至 146 億美元，到 2032 年將達到 265.1 億美元，複合年成長率為 10.39%。

主要市場統計數據
基準年 2025 132.6億美元
預計年份：2026年 146億美元
預測年份 2032 265.1億美元
複合年成長率 (%) 10.39%

全面概述正在重塑心臟瓣膜器械市場和相關人員策略的先進臨床、監管和營運促進因素。

心臟瓣膜器械領域正處於日益成長的臨床需求與快速技術進步的交匯點。器械設計、影像技術和微創植入技術的進步，加上臨床醫生專業知識的不斷提升和診療路徑的不斷演進，正在重塑心臟瓣膜疾病的治療流程。隨著病患群體老化和診斷能力的提高，器材製造商、醫療系統和專科診所等相關人員既面臨著將創新轉化為可衡量的臨床獲益的機遇，也肩負著相應的責任。

技術進步、證據日趨成熟以及策略聯盟如何重塑該領域的臨床引進、供應鏈和競爭格局。

近年來，我們見證了變革性的改變，這些改變並非只是對產品的漸進式改進，而是正在重塑醫療服務模式和商業性格局。器械小型化、新一代組織療法以及影像引導植入技術的進步，共同降低了手術風險，並擴大了微創介入治療的範圍。同時，實證醫學證據的累積日趨成熟，隨機對照試驗和真實世界臨床註冊研究的結果擴大被納入指南更新和支付方（保險公司）的政策決策中，從而加速了特定患者群體對這些技術的接受度。

評估 2025 年美國關稅政策對整個心臟瓣膜設備供應鏈的成本結構、籌資策略和採購慣例的連鎖影響。

美國於2025年開始實施關稅，對包括心臟瓣膜技術在內的整體醫療設備產業的供應鏈經濟和籌資策略產生了重大影響。依賴跨境零件供應和成品運輸的製造商面臨投入成本上升和利潤率下降的壓力，迫使他們進行短期價格調整並重新專注於「服務成本」分析。為此，採購經理加快了對替代供應商進行認證、盡可能實現生產地域多角化以及重新談判長期合約以穩定供應和降低成本風險的步伐。

分段分析揭示了閥門位置、產品結構、病患年齡和醫療保健環境如何全面決定醫療設備的設計重點、臨床要求和商業化路徑。

精細的市場區隔觀點揭示了多種因素（包括瓣膜位置、產品結構、患者族群特徵和醫療環境）之間的顯著差異，這些因素共同塑造了臨床需求和商業化路徑。根據瓣膜位置，市場被分類為不同的區域進行研究：主動脈瓣、二尖瓣、肺動脈瓣和三尖瓣，每個區域都面臨獨特的解剖學挑戰、器械設計要求和臨床醫生培訓需求。例如，主動脈瓣治療仍然是經導管介入治療最成熟的領域，而二尖瓣和三尖瓣治療則擴大採用可重新定位和修復導引型可用技術。這些差異導致了不同的實證醫學需求和器械改進方向。

決定美洲、歐洲、中東和非洲以及亞太市場臨床引入、監管合規和商業化策略的區域趨勢。

區域趨勢持續影響全球主要地區心臟瓣膜器械的監管路徑、報銷環境和推廣策略。在美洲，先進的臨床試驗和大規模干預計畫與多樣化的支付模式並存，這要求提供強力的價值證明和衛生經濟學證據。許多製造商將該地區視為臨床實驗和早期商業推廣的關鍵樞紐，同時也要應對採購慣例和醫院採購結構的區域差異。

深入了解成熟新興企業如何透過產生臨床證據、創新平台、最佳化生產和基於價值的商業模式來實現差異化。

心臟瓣膜器械領域的競爭格局呈現出傳統外科手術技術、新興經導管技術和差異化平台策略相互融合的態勢。領先企業持續投資於器材改進，例如輸送系統、瓣葉材料和抗鈣化製程；而新興企業則致力於研發顛覆性創新，例如整合修復技術、聚合物瓣葉和成像功能等植入系統。與影像和數位醫療公司的合作，透過提高手術精準度和實現上市後治療效果追蹤，提升了器械的價值提案。

為高階主管提出的切實可行的策略挑戰，包括加強供應鏈韌性、使證據生成與保險公司合作保持一致，以及投資平台創新，以確保永續的臨床和商業性競爭力。

產業領導者應採取雙管齊下的策略，在短期業務永續營運和中期創新投資之間取得平衡，以掌握瓣膜治療領域不斷變化的機會。短期內，經營團隊應優先考慮供應鏈多元化，包括選擇替代零件供應商和探索區域生產方案，以降低關稅和物流風險。同時，銷售團隊應加強與醫院和臨床醫生教育計畫的夥伴關係，以維持手術量並確保所有醫療機構都能使用相關設備。

採用嚴謹的混合方法研究途徑，結合相關人員訪談、臨床證據審查、監管分析和供應鏈基準分析，確保獲得可操作的見解。

本執行摘要的研究整合基於多層次的調查方法，該方法結合了對關鍵相關人員的訪談、臨床文獻和監管文件的回顧以及實踐標竿分析。研究人員對臨床醫生、醫院採購經理和醫療設備開發人員進行了初步的定性訪談，以確定實際應用中的促進因素、流程考慮以及上市後監測實踐。這些訪談結果與同行評審的臨床試驗、指南委員會聲明和監管核准進行了交叉比對，以確保觀察到的實踐模式與正式的證據標準相符。

對瓣膜治療領域中技術、臨床和經濟因素如何全面決定創新、市場准入和供應鏈韌性的優先事項進行了簡明扼要、綜合分析。

總而言之，在技術成熟、日益嚴格的證據要求以及不斷變化的經濟壓力等因素的驅動下，心臟瓣膜器械市場正經歷著結構性變革時期。器械的侵入性正在降低，手術精度不斷提高，整合影像和數位工具的協作模式正在湧現，以提升治療效果。儘管這些趨勢為創新者提供了清晰的發展路徑，但也對產品的可製造性、監管合規性和上市後證據收集提出了更高的要求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 按瓣膜位置分類的心臟瓣膜器械市場

  • 主動脈瓣
  • 二尖瓣
  • 肺動脈瓣
  • 三尖瓣

第9章 心臟瓣膜器械市場：依產品類型分類

  • 機械心臟瓣膜
    • 二尖瓣
    • 傾斜盤
    • 籠球
  • 生物心臟瓣膜
    • 異質骨移植
    • 同種異體移植
  • 經導管心臟瓣膜

第10章：依治療類型分類的心臟瓣膜裝置市場

  • 外科瓣膜置換術（SVR）
    • 開胸手術
    • 微創心血管手術
  • 經導管瓣膜治療

第11章：心臟瓣膜裝置市場：依年齡層別分類

  • 成人版
  • 兒童
  • 老年人

第12章 心臟瓣膜裝置市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科心臟診所
  • 研究和學術機構

第13章：心臟瓣膜器械市場：依通路分類

  • 線上
  • 離線

第14章 心臟瓣膜裝置市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 心臟瓣膜器械市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 心臟瓣膜器械市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國心臟瓣膜器材市場

第18章：中國心臟瓣膜器械市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Anteris Technologies Global Corp.
  • Artivion, Inc
  • Biosensors International Group, Ltd.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Braile Biomedica
  • Colibri Heart Valve LLC
  • Corcym Srl
  • Edwards Lifesciences Corporation
  • Foldax, Inc.
  • Getinge AB
  • Lepu（Beijing）Medical Devices Co., Ltd.
  • LifeNet Health, Inc.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Peijia Medical Limited
  • Terumo Corporation
  • TTK Healthcare Limited
  • Venus Medtech（Hangzhou）Inc.
  • WL Gore & Associates, Inc.
  • Xeltis BV
Product Code: MRR-437E9896A569

The Heart Valve Devices Market was valued at USD 13.26 billion in 2025 and is projected to grow to USD 14.60 billion in 2026, with a CAGR of 10.39%, reaching USD 26.51 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 13.26 billion
Estimated Year [2026] USD 14.60 billion
Forecast Year [2032] USD 26.51 billion
CAGR (%) 10.39%

A comprehensive orientation to the advanced clinical, regulatory, and operational drivers reshaping the heart valve devices market and stakeholder strategies

The heart valve devices sector stands at the intersection of accelerating clinical need and rapid technological progression. Advances in device design, imaging, and minimally invasive delivery techniques have converged with expanded clinician expertise and evolving care pathways, reshaping treatment algorithms for valvular heart disease. As patient populations age and diagnostic detection improves, stakeholders across device manufacturers, health systems, and specialty practices face both opportunity and responsibility to translate innovation into measurable clinical benefit.

Consequently, strategic planning in this sector requires an integrated perspective that considers regulatory complexity, reimbursement variability, and the operational realities of delivering transcatheter and surgical valve therapies. This introduction frames the executive summary by emphasizing the interplay between clinical evidence development, adoption drivers, and supply chain resilience. By grounding analysis in these dimensions, decision-makers can prioritize initiatives that deliver durable value to patients while navigating a dynamic competitive landscape.

How converging technological advances, evidence maturation, and strategic partnerships are reconfiguring clinical adoption, supply chains, and competitive dynamics in the sector

Recent years have produced transformative shifts that extend beyond incremental product improvements to reconfigure care delivery models and commercial dynamics. Device miniaturization, next-generation tissue treatments, and enhanced imaging-guided implantation techniques have collectively lowered procedural risk profiles and broadened candidacy for less invasive interventions. At the same time, evidence generation has matured, with randomized trials and real-world registries increasingly informing guideline updates and payer policies, thereby accelerating adoption in selected patient cohorts.

Moreover, industry consolidation and strategic partnerships between technology developers, imaging specialists, and service providers have concentrated capabilities while creating new scale efficiencies. Concurrently, supply chain agility and component sourcing have risen as strategic priorities, prompting manufacturers to reassess manufacturing footprints and vendor diversification. Taken together, these shifts require organizations to reassess product portfolios, market access strategies, and post-market surveillance frameworks to sustain competitive advantage and ensure patient-centered outcomes.

Assessing the cascading effects of United States tariff policy in 2025 on cost structures, sourcing strategies, and procurement practices across heart valve device supply chains

The introduction of tariffs in the United States during 2025 introduced notable implications for supply chain economics and sourcing strategies across medical device categories, including heart valve technologies. Manufacturers dependent on cross-border component supply and finished-goods movement encountered increased input costs and margin pressure, prompting near-term price adjustments and renewed focus on cost-to-serve analysis. In response, procurement leaders accelerated efforts to qualify alternate suppliers, regionalize production where feasible, and renegotiate long-term contracts to stabilize supply and cost exposure.

In parallel, clinical stakeholders and hospital systems experienced potential impacts on inventory planning and capital procurement timelines. To mitigate disruption, many institutions extended lead times for elective valve procedures, prioritized domestic sourcing when clinically appropriate, and intensified collaboration with manufacturers to secure prioritized allocations. Looking forward, the tariff environment heightened incentives for vertical integration, sourced redundancy, and investment in automation to reduce unit production costs, while also reinforcing the importance of transparent regulatory compliance and trade risk management across commercial contracts.

Segment-specific analysis revealing how valve position, product architecture, patient age, and care setting collectively dictate device design priorities, clinical requirements, and commercialization pathways

A nuanced segmentation lens reveals differential dynamics across valve position, product architecture, patient demographics, and care settings that shape clinical demand and commercialization pathways. Based on Valve Position, market is studied across Aortic, Mitral, Pulmonary, and Tricuspid, each presenting unique anatomical challenges, device design imperatives, and clinician training requirements. For example, aortic interventions remain the most established arena for transcatheter approaches, while mitral and tricuspid therapies increasingly attract investment in repositionable and repair-oriented technologies. These distinctions drive distinct evidence needs and device iterations.

Based on Product Type, market is studied across Mechanical and Tissue. The Mechanical is further studied across Bileaflet and Tilting Disc. The Tissue is further studied across Bovine Pericardial and Porcine, and material selection continues to influence durability profiles, anticoagulation strategies, and patient preference. Based on Age Group, market is studied across Adult and Pediatric, where pediatric applications demand bespoke sizing, growth-accommodating designs, and long-term follow-up strategies that differ from adult therapeutic pathways. Based on End User, market is studied across Ambulatory Surgical Centers and Hospitals. The Hospitals is further studied across Community Hospital and Tertiary Care Hospital, and care setting influences procedural volumes, staffing competencies, capital equipment availability, and post-procedural care protocols. Integrating these segmentation dimensions yields targeted insights for clinical development prioritization, reimbursement engagement, and go-to-market sequencing that respond to heterogenous stakeholder requirements.

Regional dynamics that determine clinical adoption, regulatory navigation, and commercialization strategies across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Geographic dynamics continue to shape regulatory pathways, reimbursement landscapes, and deployment strategies for heart valve devices across principal global regions. In the Americas, advanced clinical adoption and high-volume interventional programs coexist with diverse payer models that demand robust value demonstrations and health-economic evidence. Many manufacturers view this region as a focal point for pivotal trials and early commercial launches, while also navigating regional differences in procurement practices and hospital purchasing structures.

Across Europe, Middle East & Africa, regulatory harmonization efforts and national reimbursement frameworks create a mosaic of access conditions, leading firms to tailor market access plans to country-specific timelines. Investment in local clinician training and registry participation has proven effective in accelerating adoption in certain European markets. In the Asia-Pacific region, demographic trends and rapidly expanding cardiovascular care capacity are driving strong interest in both transcatheter and surgical valve solutions; however, market entry strategies require careful alignment with local regulatory frameworks, cost-containment pressures, and partnership models that can support scale-up while ensuring clinical quality. Collectively, regional approaches must balance centralized R&D priorities with localized commercialization tactics to achieve sustainable market penetration.

Insights on how incumbent and emerging companies are differentiating through clinical evidence generation, platform innovation, manufacturing optimization, and value-based commercial models

Competitive positioning in the heart valve devices arena reflects a blend of legacy surgical expertise, emergent transcatheter capabilities, and differentiated platform strategies. Leading firms continue to invest in incremental device improvements such as delivery systems, leaflet materials, and anti-calcification processes, while challengers pursue disruptive innovations in repair technologies, polymeric leaflets, and imaging-integrated implantation systems. Partnerships with imaging and digital health companies augment device value propositions by improving procedural precision and enabling post-market outcome tracking.

Additionally, strategic focus areas for companies include expanding label indications through clinical programs, strengthening post-market evidence via registries, and optimizing manufacturing footprints to ensure quality and cost efficiency. Commercial models are evolving to reflect value-based contracting and outcome-linked reimbursement in select healthcare systems, necessitating stronger provider engagement and outcome measurement capabilities. Firms that combine robust clinical evidence, scalable manufacturing, and proactive market-access strategies are better positioned to convert technological advances into sustained clinical adoption and commercial performance.

Actionable strategic imperatives for executives to strengthen supply resilience, align evidence generation with payers, and invest in platform innovations to secure durable clinical and commercial advantage

Industry leaders should pursue a dual-track strategy that balances near-term operational resilience with medium-term innovation investment to capture evolving opportunities in valve therapy. In the near term, executives should prioritize supply chain diversification, including qualifying alternate component suppliers and exploring regional manufacturing options to reduce tariff and logistics exposure. Simultaneously, commercial teams should strengthen hospital partnerships and clinician education programs to preserve procedural volumes and ensure consistent device utilization across care settings.

Over the medium term, organizations must invest in clinically meaningful differentiation such as tissue treatments that extend durability, delivery systems that simplify implantation, and digital tools that support patient selection and follow-up. Companies should also align evidence plans with payer requirements early in product development to facilitate smoother market access. Finally, pursuing strategic collaborations-whether with imaging specialists, contract manufacturers, or regional distributors-will accelerate scale and reduce time to market, enabling firms to convert technical leadership into commercial advantage while maintaining focus on patient outcomes.

A rigorous mixed-methods research approach combining stakeholder interviews, clinical evidence review, regulatory analysis, and supply chain benchmarking to ensure actionable insights

The research synthesis underpinning this executive summary draws on a layered methodology that integrates primary stakeholder interviews, clinical literature review, regulatory documentation, and operational benchmarking. Primary qualitative interviews were conducted with clinicians, hospital procurement leaders, and device developers to surface real-world adoption drivers, procedural workflow considerations, and post-market surveillance practices. These insights were triangulated with peer-reviewed clinical trials, guideline committee statements, and regulatory approvals to ensure alignment between observed practice patterns and formal evidence thresholds.

To capture commercial and operational dynamics, the methodology incorporated supply chain mapping and vendor ecosystem analysis, examining manufacturing footprints, component sourcing dependencies, and distribution channels. Wherever possible, findings were validated through cross-referencing multiple independent sources and through iterative expert review to enhance reliability. This mixed-methods approach ensures that strategic recommendations rest on both empirical evidence and practical, on-the-ground knowledge of clinical and commercial realities.

A concise synthesis of how technological, clinical, and economic forces collectively define priorities for innovation, market access, and supply chain resilience in valve therapy

In summary, the heart valve devices landscape is undergoing a period of structural change driven by technological maturation, increasingly sophisticated evidence requirements, and shifting economic pressures. Devices are becoming less invasive, procedural precision is improving, and collaborative models are emerging that integrate imaging and digital tools to enhance outcomes. These trends create clear pathways for innovators, but they also raise the bar for manufacturability, regulatory preparedness, and post-market evidence collection.

As stakeholders navigate tariff-related cost pressures, varied regional access conditions, and the nuances of segment-specific demand, success will favor organizations that adopt an integrated strategy: resilient and adaptable supply chains, targeted clinical development that aligns with payer evidence needs, and commercial models that prioritize outcomes and provider partnerships. By focusing on these priorities, companies can convert scientific progress into reproducible clinical benefit and sustainable commercial performance across diverse care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Heart Valve Devices Market, by Valve Position

  • 8.1. Aortic Valve
  • 8.2. Mitral Valve
  • 8.3. Pulmonary Valve
  • 8.4. Tricuspid Valve

9. Heart Valve Devices Market, by Product Type

  • 9.1. Mechanical Heart Valves
    • 9.1.1. Bileaflet
    • 9.1.2. Tilting Disc
    • 9.1.3. Caged Ball
  • 9.2. Biological Heart Valves
    • 9.2.1. Xenograft
    • 9.2.2. Homograft
  • 9.3. Transcatheter Heart Valves

10. Heart Valve Devices Market, by Procedure Type

  • 10.1. Surgical Valve Replacement (SVR)
    • 10.1.1. Open-Heart Surgery
    • 10.1.2. Minimally Invasive Cardiac Surgery
  • 10.2. Transcatheter Valve Interventions

11. Heart Valve Devices Market, by Age Group

  • 11.1. Adult
  • 11.2. Pediatric
  • 11.3. Geriatric

12. Heart Valve Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals
  • 12.3. Specialty Cardiology Clinics
  • 12.4. Research & Academic Centers

13. Heart Valve Devices Market, by Distribution Channel

  • 13.1. Online
  • 13.2. Offline

14. Heart Valve Devices Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Heart Valve Devices Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Heart Valve Devices Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Heart Valve Devices Market

18. China Heart Valve Devices Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Anteris Technologies Global Corp.
  • 19.7. Artivion, Inc
  • 19.8. Biosensors International Group, Ltd.
  • 19.9. BIOTRONIK SE & Co. KG
  • 19.10. Boston Scientific Corporation
  • 19.11. Braile Biomedica
  • 19.12. Colibri Heart Valve LLC
  • 19.13. Corcym S.r.l.
  • 19.14. Edwards Lifesciences Corporation
  • 19.15. Foldax, Inc.
  • 19.16. Getinge AB
  • 19.17. Lepu (Beijing) Medical Devices Co., Ltd.
  • 19.18. LifeNet Health, Inc.
  • 19.19. Medtronic plc
  • 19.20. Meril Life Sciences Pvt. Ltd.
  • 19.21. MicroPort Scientific Corporation
  • 19.22. Peijia Medical Limited
  • 19.23. Terumo Corporation
  • 19.24. TTK Healthcare Limited
  • 19.25. Venus Medtech (Hangzhou) Inc.
  • 19.26. W. L. Gore & Associates, Inc.
  • 19.27. Xeltis B.V.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HEART VALVE DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HEART VALVE DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AORTIC VALVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AORTIC VALVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AORTIC VALVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MITRAL VALVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MITRAL VALVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MITRAL VALVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PULMONARY VALVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PULMONARY VALVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PULMONARY VALVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TRICUSPID VALVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TRICUSPID VALVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TRICUSPID VALVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY BILEAFLET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY BILEAFLET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY BILEAFLET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TILTING DISC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TILTING DISC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TILTING DISC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY CAGED BALL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY CAGED BALL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY CAGED BALL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY XENOGRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY XENOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY XENOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY HOMOGRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY HOMOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY HOMOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT (SVR), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT (SVR), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT (SVR), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT (SVR), 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY OPEN-HEART SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY OPEN-HEART SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY OPEN-HEART SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MINIMALLY INVASIVE CARDIAC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MINIMALLY INVASIVE CARDIAC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MINIMALLY INVASIVE CARDIAC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER VALVE INTERVENTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER VALVE INTERVENTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TRANSCATHETER VALVE INTERVENTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY SPECIALTY CARDIOLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY SPECIALTY CARDIOLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY SPECIALTY CARDIOLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY RESEARCH & ACADEMIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY RESEARCH & ACADEMIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY RESEARCH & ACADEMIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT (SVR), 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT (SVR), 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT (SVR), 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT (SVR), 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE HEART VALVE DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT (SVR), 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT (SVR), 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA HEART VALVE DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT (SVR), 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT (SVR), 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN HEART VALVE DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT (SVR), 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. GCC HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. GCC HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 180. GCC HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. GCC HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 182. GCC HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 183. GCC HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. GCC HEART VALVE DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT (SVR), 2018-2032 (USD MILLION)
  • TABLE 185. GCC HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. GCC HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. GCC HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT (SVR), 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS HEART VALVE DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT (SVR), 2018-2032 (USD MILLION)
  • TABLE 205. BRICS HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 208. G7 HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. G7 HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 210. G7 HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. G7 HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 212. G7 HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 213. G7 HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. G7 HEART VALVE DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT (SVR), 2018-2032 (USD MILLION)
  • TABLE 215. G7 HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 216. G7 HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. G7 HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 218. NATO HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. NATO HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 220. NATO HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. NATO HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 222. NATO HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 223. NATO HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. NATO HEART VALVE DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT (SVR), 2018-2032 (USD MILLION)
  • TABLE 225. NATO HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 226. NATO HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. NATO HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT (SVR), 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA HEART VALVE DEVICES MARKET SIZE, BY BIOLOGICAL HEART VALVES, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA HEART VALVE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA HEART VALVE DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT (SVR), 2018-2032 (USD MILLION)
  • TABLE 246. CHINA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA HEART VALVE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)